Pulmonary Sarcoidosis Market Insight 2032: Clinical Trials, Revenue, Statistics, EMA, PDMA, FDA Approvals, Medication, Therapies, Prevalence, Companies by DelveInsight

(Albany, USA) DelveInsight's "Pulmonary Sarcoidosis Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Pulmonary Sarcoidosis, historical and forecasted epidemiology as well as the Pulmonary Sarcoidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Pulmonary Sarcoidosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Pulmonary Sarcoidosis pipeline products will significantly revolutionize the Pulmonary Sarcoidosis market dynamics.

The Pulmonary Sarcoidosis market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.

To Know in detail about the Pulmonary Sarcoidosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pulmonary Sarcoidosis Market Insights
https://www.delveinsight.com/sample-request/pulmonary-sarcoidosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of the key facts of the Pulmonary Sarcoidosis Market Report:
• The Pulmonary Sarcoidosis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In April 2025, New preclinical research in pulmonary sarcoidosis supports the therapeutic promise of efzofitimod, Atyr Pharma's investigational treatment currently in a Phase 3 trial. The study showed that HARS-WHEP-a protein whose function efzofitimod replicates-can help reduce inflammation in pulmonary sarcoidosis by targeting a specific receptor on immune cells.
• In March 2025, The Phase II clinical trial (KITE) evaluating OATD-01 for the treatment of pulmonary sarcoidosis has been initiated at sites across the USA and Europe. Several patients with pulmonary sarcoidosis have already been randomized and received either OATD-01 or a placebo.
• In March 2025, aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical-stage biotech company developing first-in-class therapies from its proprietary tRNA synthetase platform, announced the results of a fourth planned interim safety review for its ongoing Phase 3 EFZO-FITTM trial. Conducted by an independent data and safety monitoring board (DSMB), the analysis supported the continuation of the study without any changes, affirming the safety profile of the company's lead candidate, efzofitimod, in patients with pulmonary sarcoidosis.
• In a study by Denning DW et al. (2013), published in European Respiratory Journal, out of total patients of Sarcoidosis, approximately 90% of patients have pulmonary sarcoidosis which is characterized by the accumulation of granulomas, or small clusters of immune cells, in the lungs, potentially leading to enlarged lymph nodes, pulmonary hypertension, and fibrosis
• Key Pulmonary Sarcoidosis Companies: aTyr Pharma, Inc., Kinevant Sciences GmbH, aTyr Pharma, Inc., Novartis Pharmaceuticals, Mallinckrodt, Kinevant Sciences GmbH, Actelion, and others
• Key Pulmonary Sarcoidosis Therapies: ATYR1923, Namilumab, CMK389, Efzofitimod, CMK389, ACZ885, Acthar Gel, Namilumab, Selexipag, Bosentan, and others
• The Pulmonary Sarcoidosis epidemiology based on gender analyzed that Pulmonary Sarcoidosis is more common in women than in men

Get a Free sample for the Pulmonary Sarcoidosis Market Report
https://www.delveinsight.com/report-store/pulmonary-sarcoidosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Pulmonary Sarcoidosis Overview
Pulmonary Sarcoidosis is a chronic inflammatory disease characterized by the formation of non-caseating granulomas in the lungs. Pulmonary Sarcoidosis primarily affects the alveoli, bronchi, and lymph nodes, leading to impaired respiratory function. Pulmonary Sarcoidosis is of unknown etiology but is believed to be triggered by an exaggerated immune response to environmental or infectious agents.

Pulmonary Sarcoidosis commonly manifests between the ages of 20 and 40 and is more prevalent among African Americans and Northern Europeans. Pulmonary Sarcoidosis symptoms include persistent dry cough, chest pain, and shortness of breath, although many patients remain asymptomatic.

Pulmonary Sarcoidosis diagnosis involves imaging techniques such as chest X-rays and high-resolution CT scans, along with pulmonary function tests and tissue biopsy. Pulmonary Sarcoidosis may resolve spontaneously in some cases, but chronic cases can lead to pulmonary fibrosis and respiratory failure. Pulmonary Sarcoidosis treatment typically includes corticosteroids to reduce inflammation, with immunosuppressive agents used in severe or refractory cases.

Pulmonary Sarcoidosis prognosis varies; while many experience remission, others may suffer from long-term complications. Pulmonary Sarcoidosis management requires regular monitoring and a multidisciplinary approach. Pulmonary Sarcoidosis research continues to focus on identifying genetic markers and novel therapeutic targets to improve patient outcomes.

Pulmonary Sarcoidosis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Pulmonary Sarcoidosis Epidemiology Segmentation:
The Pulmonary Sarcoidosis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Pulmonary Sarcoidosis
• Prevalent Cases of Pulmonary Sarcoidosis by severity
• Gender-specific Prevalence of Pulmonary Sarcoidosis
• Diagnosed Cases of Episodic and Chronic Pulmonary Sarcoidosis

Download the report to understand which factors are driving Pulmonary Sarcoidosis epidemiology trends @ Pulmonary Sarcoidosis Epidemiological Insights
https://www.delveinsight.com/sample-request/pulmonary-sarcoidosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Pulmonary Sarcoidosis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Pulmonary Sarcoidosis market or expected to get launched during the study period. The analysis covers Pulmonary Sarcoidosis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Pulmonary Sarcoidosis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Pulmonary Sarcoidosis Therapies and Key Companies
• ATYR1923: aTyr Pharma, Inc.
• Namilumab: Kinevant Sciences GmbH
• CMK389: Novartis
• Efzofitimod: aTyr Pharma, Inc.
• CMK389: Novartis Pharmaceuticals
• ACZ885: Novartis
• Acthar Gel: Mallinckrodt
• Namilumab: Kinevant Sciences GmbH
• Selexipag: Actelion
• Bosentan: Actelion

To know more about Pulmonary Sarcoidosis treatment, visit @ Pulmonary Sarcoidosis Medications
https://www.delveinsight.com/sample-request/pulmonary-sarcoidosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of the Pulmonary Sarcoidosis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Pulmonary Sarcoidosis Companies: aTyr Pharma, Inc., Kinevant Sciences GmbH, Novartis, aTyr Pharma, Inc., Novartis Pharmaceuticals, Mallinckrodt, Kinevant Sciences GmbH, Actelion, and others
• Key Pulmonary Sarcoidosis Therapies: ATYR1923, Namilumab, CMK389, Efzofitimod, CMK389, ACZ885, Acthar Gel, Namilumab, Selexipag, Bosentan, and others
• Pulmonary Sarcoidosis Therapeutic Assessment: Pulmonary Sarcoidosis current marketed and Pulmonary Sarcoidosis emerging therapies
• Pulmonary Sarcoidosis Market Dynamics: Pulmonary Sarcoidosis market drivers and Pulmonary Sarcoidosis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Pulmonary Sarcoidosis Unmet Needs, KOL's views, Analyst's views, Pulmonary Sarcoidosis Market Access and Reimbursement

Discover more about therapies set to grab major Pulmonary Sarcoidosis emerging therapies @ Pulmonary Sarcoidosis Therapeutic Assessment
https://www.delveinsight.com/sample-request/pulmonary-sarcoidosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents
1. Pulmonary Sarcoidosis Market Report Introduction
2. Executive Summary for Pulmonary Sarcoidosis
3. SWOT analysis of Pulmonary Sarcoidosis
4. Pulmonary Sarcoidosis Patient Share (%) Overview at a Glance
5. Pulmonary Sarcoidosis Market Overview at a Glance
6. Pulmonary Sarcoidosis Disease Background and Overview
7. Pulmonary Sarcoidosis Epidemiology and Patient Population
8. Country-Specific Patient Population of Pulmonary Sarcoidosis
9. Pulmonary Sarcoidosis Current Treatment and Medical Practices
10. Pulmonary Sarcoidosis Unmet Needs
11. Pulmonary Sarcoidosis Emerging Therapies
12. Pulmonary Sarcoidosis Market Outlook
13. Country-Wise Pulmonary Sarcoidosis Market Analysis (2019-2032)
14. Pulmonary Sarcoidosis Market Access and Reimbursement of Therapies
15. Pulmonary Sarcoidosis Market Drivers
16. Pulmonary Sarcoidosis Market Barriers
17. Pulmonary Sarcoidosis Appendix
18. Pulmonary Sarcoidosis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:

Pulmonary Sarcoidosis Pipeline https://www.delveinsight.com/report-store/pulmonary-sarcoidosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
"Pulmonary Sarcoidosis Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Pulmonary Sarcoidosis market. A detailed picture of the Pulmonary Sarcoidosis pipeline landscape is provided, which includes the disease overview and Pulmonary Sarcoidosis treatment guidelines.

Pulmonary Sarcoidosis Epidemiology https://www.delveinsight.com/report-store/pulmonary-sarcoidosis-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
DelveInsight's 'Pulmonary Sarcoidosis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Pulmonary Sarcoidosis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Trending Reports:
• Absssi Market Size: https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infection-absssi-market-insights-epidemiology-and-market-forecast
• Acquired Immunodeficiency Syndrome Market: https://www.delveinsight.com/report-store/acquired-immunodeficiency-syndrome-aids-market
• Actinic Keratosis Market: https://www.delveinsight.com/infographics/actinic-keratosis-market
• Acute Intermittent Porphyria Market: https://www.delveinsight.com/report-store/acute-intermittent-porphyria-market
• Ashermans Syndrome Market: https://www.delveinsight.com/report-store/ashermans-syndrome-market
• Bacterial Skin Diseases Market: https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infections-market
• Biliary Stents Market: https://www.delveinsight.com/report-store/biliary-stents-market
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
• Bone Densitometers Market: https://www.delveinsight.com/blog/bone-densitometers-market-analysis
• Carpal Tunnel Syndrome Market: https://www.delveinsight.com/report-store/carpal-tunnel-release-system-market
• Diabetic Neuropathy Market: https://www.delveinsight.com/report-store/diabetic-peripheral-neuropathy-market
• Duchenne Muscular Dystrophy Market: https://www.delveinsight.com/blog/duchenne-muscular-dystrophy-market
• Eczema Market: https://www.delveinsight.com/report-store/eczema-market
• Exocrine Pancreatic Insufficiency Market: https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-epi-market
• Head And Neck Squamous Cell Carcinoma Market: https://www.delveinsight.com/report-store/head-and-neck-cancer-hnc-market
• Hemodynamic Monitoring Systems Market: https://www.delveinsight.com/report-store/hemodynamic-monitoring-system-market
• Hepatitis B Virus Market: https://www.delveinsight.com/report-store/chronic-hepatitis-b-virus-market
• Implantable Infusion Pumps Market: https://www.delveinsight.com/report-store/implantable-infusion-pumps-market
• Multiple Myeloma Market: https://www.delveinsight.com/report-store/multiple-myeloma-market
• Pharma Competitive Intelligence: https://www.delveinsight.com/blog/competitive-intelligence-in-healthcare-sector
• Precocious Puberty Market: https://www.delveinsight.com/report-store/precocious-puberty-market
• Walking Impairment In Multiple Sclerosis Market: https://www.delveinsight.com/report-store/walking-impairment-in-multiple-sclerosis-market
• Anaphylaxis Market: https://www.delveinsight.com/report-store/anaphylaxis-market
• Biochips Market: https://www.delveinsight.com/blog/biochips-market-landscape
• Central Venous Catheters Market: https://www.delveinsight.com/report-store/central-venous-catheters-market
• Contraceptive Devices Market: https://www.delveinsight.com/report-store/contraceptive-devices-market
• Diabetic Foot Ulcers Dfus Market: https://www.delveinsight.com/infographics/diabetic-foot-ulcers-dfus-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/audiology-devices-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Intracranial Pressure Monitoring Devices Market: https://www.delveinsight.com/report-store/intracranial-pressure-monitoring-devices-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Ophthalmic Imaging Equipment Market: https://www.delveinsight.com/report-store/ophthalmic-imaging-equipment-market
• Osteoarthritis Market: https://www.delveinsight.com/report-store/knee-osteoarthritis-market
• Pruritus Market: https://www.delveinsight.com/report-store/chronic-pruritus-market
• Surgical Stapling Devices Market: https://www.delveinsight.com/report-store/surgical-stapling-devices-market
• Wound Closure Devices Market: https://www.delveinsight.com/report-store/wound-closure-device-market
• Apheresis Market: https://www.delveinsight.com/report-store/apheresis-market
• Arteriovenous Fistula Market: https://www.delveinsight.com/report-store/arteriovenous-fistula-market
• Atypical Teratoid Rhabdoid Tumors Market: https://www.delveinsight.com/report-store/atypical-teratoid-rhabdoid-tumors-atrt-epidemiology-forecast
• Bladder Cancer Market: https://www.delveinsight.com/report-store/non-muscle-invasive-bladder-cancer-market
• Catheter-related Bloodstream Infections Market: https://www.delveinsight.com/report-store/catheter-related-bloodstream-infection-market
• Central Pain Syndrome Market: https://www.delveinsight.com/report-store/central-pain-syndrome-market
• Fibrocystic Breast Condition Market: https://www.delveinsight.com/report-store/fibrocystic-breast-condition-epidemiology-forecast
• Global Electrophysiology Devices Market: https://www.delveinsight.com/report-store/electrophysiology-devices-market
• Interbody Cages Market: https://www.delveinsight.com/report-store/interbody-cages-market
• Neurostimulation Devices Market: https://www.delveinsight.com/report-store/neurostimulation-devices-market
• Nsclc Market: https://www.delveinsight.com/report-store/non-small-cell-lung-cancer-nsclc-market
• Palmar Hyperhidrosis Market: https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market
• Palmar Hyperhidrosis Market Size: https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market
• Pressure Ulcers Market: https://www.delveinsight.com/report-store/pressure-ulcers-market
• Allergic Rhinitis Market: https://www.delveinsight.com/report-store/allergic-rhinitis-market
• Anti-cd274 Pd-l1 Antibody Pipeline: https://www.delveinsight.com/report-store/pd-1-and-pd-l1-inhibitors-competitive-landscape
• Arthroscopy Devices Market: https://www.delveinsight.com/report-store/arthroscopy-devices-market
• Cervical Intraepithelial Neoplasia Market: https://www.delveinsight.com/report-store/cervical-cancer-market
• Cough Assisted Device Market: https://www.delveinsight.com/report-store/cough-assist-devices-market
• Foot And Ankle Devices Market: https://www.delveinsight.com/report-store/foot-and-ankle-devices-market
• Minimal Residual Disease Market: https://www.delveinsight.com/report-store/minimal-residual-disease-market
• Pharma Licensing Services: https://www.delveinsight.com/consulting/licensing-services
• X Linked Hypophosphatemia Market: https://www.delveinsight.com/report-store/x-linked-hypophosphatemia-market
• Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market
• Androgenetic Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Image Guided Surgery Devices Market: https://www.delveinsight.com/report-store/image-guided-surgery-devices-market
• Non Alcoholic Fatty Liver Disease Nafld Market: https://www.delveinsight.com/report-store/non-alcoholic-fatty-liver-disease-nafld-market
• Artificial Kidney Market: https://www.delveinsight.com/report-store/artificial-kidney-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Healthcare Due Diligence Services: https://www.delveinsight.com/consulting/due-diligence-services
• Hearing Implants Market: https://www.delveinsight.com/report-store/hearing-implants-market
• Pulse Oximeter Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Radioligand Therapies Market: https://www.delveinsight.com/report-store/radioligand-therapies-market-forecast
• Continuous Renal Replacement Therapy Machines Market: https://www.delveinsight.com/report-store/continuous-renal-replacement-therapy-machines-market
• Dysthymia Market: https://www.delveinsight.com/report-store/major-depressive-disorder-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Menopause Market: https://www.delveinsight.com/report-store/menopause-market-forecast
• Prefilled Syringes Market: https://www.delveinsight.com/report-store/prefilled-syringes-market
• Gaucher Disease Market: https://www.delveinsight.com/report-store/gauchers-disease-market
• Healthcare Competitive Benchmarking: https://www.delveinsight.com/consulting/competitive-benchmarking-services
• Healthcare Subscription Models: https://www.delveinsight.com/blog/subscription-model-in-healthcare
• Wound Irrigation Systems Market: https://www.delveinsight.com/report-store/wound-irrigation-systems-market
• Benefits Of Robotics In Healthcare: https://www.delveinsight.com/blog/robotics-in-healthcare
• Adamantinoma Market: https://www.delveinsight.com/blog/bone-cancer-treatment-market
• Trigeminal Neuralgia Market Size: https://www.delveinsight.com/report-store/chronic-pain-market
• Xerostomia Market: https://www.delveinsight.com/report-store/xerostomia-pipeline-insight
• Abetalipoproteinemia Market: https://www.delveinsight.com/report-store/abetalipoproteinemia-market
• Astigmatism Market: https://www.delveinsight.com/report-store/astigmatism-market
• Calcinosis Cutis Market: https://www.delveinsight.com/report-store/calcinosis-cutis-market
• Cardiotoxicity Market: https://www.delveinsight.com/report-store/cardiotoxicity-market
• Molecular Glue Market: https://www.delveinsight.com/report-store/molecular-glues-market-forecast
• Pneumoconiosis Market: https://www.delveinsight.com/report-store/pneumoconiosis-market
• Polypoidal Choroidal Vasculopathy Market: https://www.delveinsight.com/report-store/polypoidal-choroidal-vasculopathy-market
• Sts Devices Market: https://www.delveinsight.com/report-store/sts-devices-market

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/ats-conference-coverage

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.